Parathyroidectomy reduces 25-hydroxyvitamin D3-1 alpha-hydroxylase activity in the hypocalcemic vitamin D-deficient chick.
Open Access
- 1 December 1977
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 60 (6) , 1314-1320
- https://doi.org/10.1172/jci108890
Abstract
To test the hypothesis that in the vitamin D-deficient state the activity of 25-hydroxyvitamin D3-1 alpha-hydroxylase (25-OHD3-1 alpha-hydroxylase) is modulated by parathyroid hormone and the plasma concentration of phosphate only in the presence of small amounts of 1,25-dihydroxyvitamin D3 (or some other metabolite of vitamin D), we measured the activity of this enzyme 24 h after parathyroidectomy (PTX) in frankly hypocalcemic, vitamin D-deficient chicks that were not supplemented with vitamin D or one of its metabolites. The otherwise predictable complications of PTX in this metabolic setting (hypocalcemia of increasing severity, tetany, moribundity, and death) were prevented by continuous intravenous administration of calcium (as a solution of calcium chloride/calcium gluconate 1:1) through a catheter in the external jugular vein placed at the time of PTX. The findings were as follows: (a) The activity of 25-OHD3-1 alpha-hydroxylase was significantly less in the parathyroidectomized group than in the sham-operated control chicks (P less than 0.001). (b) The reductive effect of PTX on the activity of this enzyme was significantly attenuated when hypophosphatemia was increased in severity by administration of glucose. (c) In the post-PTX state the activity of 25-OHD3-1 alpha-hydroxylase and plasma concentration of phosphate were significantly, inversely related (P less than 0.001). (d) In the sham-operated control group the activity of this enzyme and the plasma concentration of phosphate were not significantly correlated. These findings indicate that in the vitamin D-deficient state, both circulating parathyroid hormone and the plasma concentration of phosphate can significantly modulate the activity of 25-OHD3-1 alpha-hydroxylase in the absence of vitamin D or its metabolites. The findings also suggest that in the vitamin D-deficient state the plasma concentration of phosphate modulates the activity of this enzyme only when the concentration of circulating parathyroid hormone is not increased.This publication has 26 references indexed in Scilit:
- Studies on Calciferol Metabolism. VI. The Renal Production of the Biologically Active Form of Vitamin D, 1,25-Dihydroxycholecalciferol; Species, Tissue and Subcellular Distribution1Journal of Clinical Endocrinology & Metabolism, 1973
- Isolation and identification of 24,25-dihydroxycholecalciferol, a metabolite of vitamin D3 made in the kidneyBiochemistry, 1972
- Hormonal control of the renal conversion of 25-hydroxycholecalciferol to 1,25-dihydroxycholecalciferolJournal of Clinical Investigation, 1972
- Control of 25-Hydroxycholecalciferol Metabolism by Parathyroid GlandsProceedings of the National Academy of Sciences, 1972
- 1,25-Dihydroxycholecalciferol: Metabolite of Vitamin D 3 Active on Bone in Anephric RatsScience, 1972
- The Metabolism of Vitamin D3 in the ChickJournal of Biological Chemistry, 1972
- The Response of Intestinal Calcium Transport to 25-Hydroxy and 1,25-Dihydroxy Vitamin D in Nephrectomized RatsEndocrinology, 1972
- Regulation by Calcium of In Vivo Synthesis of 1,25-Dihydroxycholecalciferol and 21,25-DihydroxycholecalciferolProceedings of the National Academy of Sciences, 1971
- A new chromatographic system for vitamin D3 and its metabolites: resoluation of a new vitamin D3 metabolite.1971
- Vitamin D Metabolism: The Role of Kidney TissueScience, 1971